Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BREXTEM-H
- Development stage
- Unknown
- Lead developer
- Brexogen
- Modality
- Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
BREXTEM-H is a specialized exosome-based treatment developed by Brexogen, a South Korea-based biotech innovator, for enhancing scalp vitality and supporting stronger, healthier hair growth. Launched in mid-2025, this product is formulated with human cord blood-induced pluripotent cell-derived exosomes, along with panthenol, niacinamide, hydrolyzed keratin, biotin, and plant extracts. It functions by activating dermal papilla cells, reducing inflammation, promoting follicle regeneration, stimulating hair follicles, and improving hair quality through the proliferation of hair follicle cells. The treatment leverages Brexogen's proprietary "Natural Biomacromolecule Cargo-Controlled Exosome Platform" to deliver nano-sized vesicles enriched with proteins, miRNAs, peptides, and growth factors. It is intended for clinical and hospital use as an aesthetic platform solution for various types of hair loss, including androgenic alopecia and alopecia areata.
- Brand names
- BREXTEM-HBREXTEM HAIRBREXTEM HAIR LOSS CARE EXOSOME
Beyond the preview
Go deeper on BREXTEM-H.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BREXTEM-H.